JP2021501592A - 遺伝子調節 - Google Patents

遺伝子調節 Download PDF

Info

Publication number
JP2021501592A
JP2021501592A JP2020524490A JP2020524490A JP2021501592A JP 2021501592 A JP2021501592 A JP 2021501592A JP 2020524490 A JP2020524490 A JP 2020524490A JP 2020524490 A JP2020524490 A JP 2020524490A JP 2021501592 A JP2021501592 A JP 2021501592A
Authority
JP
Japan
Prior art keywords
chromosomal
interactions
nucleic acids
probe
chromosomal interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020524490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021501592A5 (enExample
Inventor
アクーリチェフ、アレクサンドル
セルヴァム ラマダス、アロウル
セルヴァム ラマダス、アロウル
ハンター、ユアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biodynamics PLC
Original Assignee
Oxford Biodynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biodynamics PLC filed Critical Oxford Biodynamics PLC
Publication of JP2021501592A publication Critical patent/JP2021501592A/ja
Publication of JP2021501592A5 publication Critical patent/JP2021501592A5/ja
Priority to JP2023060384A priority Critical patent/JP7631400B2/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2020524490A 2017-11-03 2018-11-02 遺伝子調節 Pending JP2021501592A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023060384A JP7631400B2 (ja) 2017-11-03 2023-04-03 遺伝子調節

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762581287P 2017-11-03 2017-11-03
US62/581,287 2017-11-03
GBPCT/GB2018/052818 2018-10-03
GB2018052818 2018-10-03
PCT/GB2018/053196 WO2019086898A2 (en) 2017-11-03 2018-11-02 Genetic regulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023060384A Division JP7631400B2 (ja) 2017-11-03 2023-04-03 遺伝子調節

Publications (2)

Publication Number Publication Date
JP2021501592A true JP2021501592A (ja) 2021-01-21
JP2021501592A5 JP2021501592A5 (enExample) 2021-12-09

Family

ID=64661410

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020524490A Pending JP2021501592A (ja) 2017-11-03 2018-11-02 遺伝子調節
JP2023060384A Active JP7631400B2 (ja) 2017-11-03 2023-04-03 遺伝子調節

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023060384A Active JP7631400B2 (ja) 2017-11-03 2023-04-03 遺伝子調節

Country Status (13)

Country Link
US (1) US11840737B2 (enExample)
EP (1) EP3704274B1 (enExample)
JP (2) JP2021501592A (enExample)
KR (1) KR102885025B1 (enExample)
CN (1) CN111511930B (enExample)
AU (1) AU2018361833B2 (enExample)
CA (1) CA3078675A1 (enExample)
ES (1) ES2987603T3 (enExample)
HU (1) HUE066292T2 (enExample)
MY (1) MY199800A (enExample)
PL (1) PL3704274T3 (enExample)
SG (1) SG11202003233YA (enExample)
WO (1) WO2019086898A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024160217A (ja) * 2020-03-17 2024-11-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 治療に対するレスポンダを決定するための方法およびシステム

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3152645A1 (en) * 2019-09-11 2021-03-18 Oxford BioDynamics PLC Diagnostic chromosome marker
GB202008269D0 (en) * 2020-06-02 2020-07-15 Oxford Biodynamics Ltd Detecting a chromosome marker
GB202016176D0 (en) * 2020-10-12 2020-11-25 Oxford BioDynamics PLC Disease marker
TW202302862A (zh) * 2021-03-04 2023-01-16 英商牛津生物力學公眾有限公司 染色體交互作用標記物
WO2025215189A1 (en) * 2024-04-12 2025-10-16 Oxford BioDynamics PLC Chromosome marker test

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515449A (ja) * 2007-01-11 2010-05-13 エラスムス ユニバーシティ メディカル センター 環状染色体コンホメーション捕捉（４ｃ）
JP2011502108A (ja) * 2007-10-15 2011-01-20 武田薬品工業株式会社 癌の予防・治療剤
WO2016207661A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection processes using sites of chromosome interaction
JP2017184729A (ja) * 2009-05-12 2017-10-12 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036993A1 (es) * 2001-04-02 2004-10-20 Wyeth Corp Uso de agentes que modulan la interaccion entre pd-1 y sus ligandos en la submodulacion de respuestas inmunologicas
GB0603251D0 (en) 2006-02-17 2006-03-29 Isis Innovation DNA conformation
GB0810051D0 (en) 2008-06-02 2008-07-09 Oxford Biodynamics Ltd Method of diagnosis
EP3004877A4 (en) * 2013-06-06 2017-04-19 Dana-Farber Cancer Institute, Inc. Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
WO2015077414A1 (en) 2013-11-20 2015-05-28 Dana-Farber Cancer Institute, Inc. Kynurenine pathway biomarkers predictive of anti-immune checkpoint inhibitor response

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010515449A (ja) * 2007-01-11 2010-05-13 エラスムス ユニバーシティ メディカル センター 環状染色体コンホメーション捕捉（４ｃ）
JP2011502108A (ja) * 2007-10-15 2011-01-20 武田薬品工業株式会社 癌の予防・治療剤
JP2017184729A (ja) * 2009-05-12 2017-10-12 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 前立腺癌マーカーとしてのホスホジエステラーゼ４ｄ７
WO2016207661A1 (en) * 2015-06-24 2016-12-29 Oxford Biodynamics Limited Detection processes using sites of chromosome interaction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALEXANDRE AKOULITCHEV ET AL.: "Pharmacogenetic 3C interaction associated with the PDGFRA gene as a chromatin conformation marker fo", JOURNAL OF CLINICAL ONCOLOGY, vol. Vol. 35、Issue 15, JPN6022042014, 30 May 2017 (2017-05-30), ISSN: 0005076715 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024160217A (ja) * 2020-03-17 2024-11-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 治療に対するレスポンダを決定するための方法およびシステム

Also Published As

Publication number Publication date
CA3078675A1 (en) 2019-05-09
AU2018361833A1 (en) 2020-04-30
AU2018361833B2 (en) 2021-04-22
EP3704274A2 (en) 2020-09-09
ES2987603T3 (es) 2024-11-15
SG11202003233YA (en) 2020-05-28
MY199800A (en) 2023-11-23
HUE066292T2 (hu) 2024-07-28
US20210230702A1 (en) 2021-07-29
EP3704274C0 (en) 2024-04-17
US11840737B2 (en) 2023-12-12
KR20200081380A (ko) 2020-07-07
JP2023082157A (ja) 2023-06-13
PL3704274T3 (pl) 2024-07-08
NZ763540A (en) 2025-03-28
KR102885025B1 (ko) 2025-11-11
WO2019086898A3 (en) 2019-06-13
WO2019086898A2 (en) 2019-05-09
CN111511930B (zh) 2024-11-22
JP7631400B2 (ja) 2025-02-18
CN111511930A (zh) 2020-08-07
EP3704274B1 (en) 2024-04-17

Similar Documents

Publication Publication Date Title
JP7297015B2 (ja) エピジェネティックな染色体相互作用
AU2020264326B2 (en) Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
JP7631400B2 (ja) 遺伝子調節
JP7005596B2 (ja) 乳がんに関連する染色体相互作用の検出
JP2021535489A (ja) 無細胞ｄｎａにおけるマイクロサテライト不安定性の検出
JP2025032205A (ja) 前立腺がんおよびリンパ腫の染色体コンフォメーションマーカー
JP2023027076A (ja) がんの診断における後成的染色体相互作用の応用
JP2024504062A (ja) 染色体相互作用
JP2025108590A (ja) 診断用染色体マーカー
JP2023545364A (ja) 疾患マーカー
JP2023528621A (ja) 線維症、例えば強皮症のためのマーカーとしての染色体コンフォメーションの検出
ES3029416T3 (en) Chromosome interaction markers
CN117795098A (zh) 染色体相互作用标志物
WO2024259251A1 (en) Method for hrd detection in targeted cfdna samples using de novo mutational signatures
JPWO2020225551A5 (enExample)
Gershon Accuracy of CNV Detection from GWAS Data
Cradic Next Generation Sequencing: Applications for the Clinic
HK40033107A (en) Genetic regulation of immunoresponse by chromosome interactions
HK40033107B (en) Genetic regulation of immunoresponse by chromosome interactions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211101

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211101

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221227

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230303

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230606